+ Watch ZTS
on My Watchlist
Spin off from Pfizer animal health division Q income statement up 8% compared to same Q last yr. $1.1B. $706 M came from live segment. $ 397 from Animal division can boost funds. Acquired all of Advanced food technologies because of these investments profit dropped 19%
exploding pet demographic
- Largest animal drug manufacturer. - Recent split from parent PFE (companies normally operate more efficiently after they're split into logical operating pieces).- Not exposed to the same patent -war and FDA approval fears that the rest of Large Pharma is.
Spin off in great industry
Sales growth is expanding fast, and spinoff from Pfizer should enhance economics.
Zoetis has been the largest developer and manufacturer of veterinary vaccines and medicines and is the largest publicly traded animal health company; not a new company, but a recent spinoff from Pfizer. Zoetis is diversified in 120 different countries, with manufacturing facilities in 11 different countries and develops products specific to different areas of concerns geographically. Revenue up 7% growth; both revenues in livestock and companion animals are up from a year ago, as well as 8% growth in earnings in the U.S. alone. First quarter up 4% in revenue and 26% in net income. One of their biggest products (Convenia), which is a one-time injection used to fight skin infections in cats and dogs was launched in China this March and is now available in 50 countries. They project an approx. $1 increase to EPS this year which includes the costs associated from its separation from Pfizer; it’s already up $1.89 per share from its initial price in Feb. I believe Zoetis is prepared to stand on its own and is poised to succeed and have made it one of my own investments.
Strong product line.
Pfizer spin-off of animal care unit...http://stockcharts.com/freecharts/gallery.html?ZTS...should be an interesting development.
Pfizer seperating the animal health side of the business from the human side is a smart move.
The first publicly-traded "pure play" animal health sciences company should do well over the long-term.
IPO of spin-off Animal Health unit of Pfizer,Inc. Nice open can't believe I forgot today was the day.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions